Clinical Trial Update: Safety and Effectiveness Study of Combo Bio-engineered Sirolimus Eluting Stent [Phase 2]

View source ↗

Summary

Phase 2 safety and effectiveness study of a combo bio-engineered sirolimus-eluting stent for coronary artery lesions has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Sirolimus-eluting stent (Combo Bio-engineered) (sirolimus-eluting stent)

Snippet

Sponsor: OrbusNeich | Conditions: Coronary Artery Lesions | Phase 2 | Status: COMPLETED